1-cyclohexyl-2-piperazinone trifluoroacetate, 95.0%, 1g

(R)-2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid, 95.0%, 250mg

4-(Aminomethyl)benzonitrile Hydrochloride>98.0%(HPLC)(T)1g

3,4-Dimethoxybenzamide, 95.0%, 5g

Récipient à échantillons Type 2118, 30 ml, 12 pièce(s)

4-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 100mg

2-(4-Methyl-tetrahydro-2H-pyran-4-yl)acetic acid, 99%, 250mg

1-Methyl-1H-pyrrolo[2,3-c]pyridine, 97%, 250mg

2-Bromophenylhydrazine hydrochloride, 98.0%, 500g

4-(8-CHLORO-5H-DIBENZO[B,E][1,4]DIAZEPIN-11-YL)-1-METHYLPIPERAZINE 1-OXIDE, 95%, 500mg

(R)-2-(Diphenylphosphino)-1-phenylethanamine, 95%, 100mg

5-Hydroxy-4-methylisobenzofuran-1(3H)-one, 97.0%, 250mg

Trichlorométhane/chloroforme, 99% min, pour synthèse, 1L, conditionnement verre